A Look at Amphastar Pharmaceuticals Inc (AMPH) After 3.3% Decline -- GF Value $36.36 vs Price $25.81
gurufocus.com · 2026-10-01
On September 30, 2026, Amphastar Pharmaceuticals Inc (AMPH) shares fell 3.3% to a current price of $25.81. This decline comes amid a 52-week trading range that
TickrTrends take: Amphastar Pharmaceuticals operates in the Healthcare sector and is currently trading below the GF Value estimate, which aligns with TickrTrends' undervalued assessment. The recent decline presents a potential opportunity for value-focused investors to monitor whether the stock's price movement reflects fundamental weakness or simply a temporary pullback from fair value. Investors should watch for developments in the company's pipeline and financial performance that could explain the current discount and determine if the undervalued signal remains valid.
Read the full story at gurufocus.com →
Is AMPH undervalued? See TickrTrends' fair value analysis →